The Microbial Ecology of Human-Associated Bacterial Communities
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Contribution of the Human Microbiome and Proteus Mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy
Internet Journal of Allied Health Sciences and Practice Volume 19 Number 3 Article 6 2021 Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy Jessica Kerpez Nova Southeastern University, [email protected] Marc Kesselman Nova Southeastern University, [email protected] Michelle Demory Beckler Nova Southeastern University, [email protected] Follow this and additional works at: https://nsuworks.nova.edu/ijahsp Part of the Genetic Phenomena Commons, Genetic Processes Commons, Immune System Diseases Commons, Medical Biochemistry Commons, and the Musculoskeletal Diseases Commons Recommended Citation Kerpez J, Kesselman M, Demory Beckler M. Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy. The Internet Journal of Allied Health Sciences and Practice. 2021 Jan 01;19(3), Article 6. This Review Article is brought to you for free and open access by the College of Health Care Sciences at NSUWorks. It has been accepted for inclusion in Internet Journal of Allied Health Sciences and Practice by an authorized editor of NSUWorks. For more information, please contact [email protected]. Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy Abstract The human microbiome has been shown to play a role in the regulation of human health, behavior, and disease. Data suggests that microorganisms that co-evolved within humans have an enhanced ability to prevent the development of a large spectrum of immune-related disorders but may also lead to the onset of conditions when homeostasis is disrupted. -
Health Impact and Therapeutic Manipulation of the Gut Microbiome
Review Health Impact and Therapeutic Manipulation of the Gut Microbiome Eric Banan-Mwine Daliri 1 , Fred Kwame Ofosu 1 , Ramachandran Chelliah 1, Byong Hoon Lee 2,3,* and Deog-Hwan Oh 1 1 Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, Korea; [email protected] (E.B.-M.D.); [email protected] (F.K.O.); [email protected] (R.C.); [email protected] (D.-H.O.) 2 Department of Microbiology/Immunology, McGill University, Montreal, QC H3A 2B4, Canada 3 SportBiomics, Sacramento Inc., Sacramento, CA 95660, USA * Correspondence: [email protected] Received: 24 March 2020; Accepted: 19 July 2020; Published: 29 July 2020 Abstract: Recent advances in microbiome studies have revealed much information about how the gut virome, mycobiome, and gut bacteria influence health and disease. Over the years, many studies have reported associations between the gut microflora under different pathological conditions. However, information about the role of gut metabolites and the mechanisms by which the gut microbiota affect health and disease does not provide enough evidence. Recent advances in next-generation sequencing and metabolomics coupled with large, randomized clinical trials are helping scientists to understand whether gut dysbiosis precedes pathology or gut dysbiosis is secondary to pathology. In this review, we discuss our current knowledge on the impact of gut bacteria, virome, and mycobiome interactions with the host and how they could be manipulated to promote health. Keywords: microbiome; biomarkers; personalized nutrition; microbes; metagenomics 1. Introduction The human body consists of mammalian cells and many microbial cells (bacteria, viruses, and fungi) which co-exist symbiotically. -
Antimicrobial Resistance in Mycobacterium Tuberculosis: the Odd One Out
1 Antimicrobial Resistance in Mycobacterium tuberculosis: the Odd One Out 2 3 Vegard Eldholm1 and François Balloux2 4 5 Correspondance: Vegard Eldholm [email protected] 6 François Balloux [email protected] 7 8 1. Division of Infectious Disease Control, Norwegian Institute of PuBlic Health, LovisenBerggata 9 8, Oslo 0456, Norway 10 2. Department of Genetics, Evolution and Environment, University College London, Darwin 11 Building, Gower Street, London WC1E 6BT, UK 12 13 Keywords 14 TuBerculosis, AntiBiotics, Evolution, Mutation, Transmission, Latency, Biofilms 15 1 16 Abstract 17 AntimicroBial resistance (AMR) threats are typically represented By Bacteria capable of 18 extensive horizontal gene transfer (HGT). One clear exception is Mycobacterium tuberculosis 19 (Mtb). It is an oBligate human pathogen with limited genetic diversity and a low mutation rate 20 which further lacks any evidence for HGT. Such features should in principle reduce its ability to 21 rapidly evolve AMR. We identify key features in its Biology and epidemiology that allows it to 22 overcome its low adaptive potential. We focus in particular on its innate resistance to drugs, 23 unusual life cycle including an often extensive latent phase and its ability to shelter from 24 exposure to antimicroBial drugs within cavities it induces in the lungs. 2 25 So Special 26 The rapid increase of antimicrobial resistance (AMR; see Glossary) in Bacteria is driven By the 27 widespread use, abuse and misuse of antiBiotics, and constitutes one of the most challenging 28 healthcare proBlems gloBally. With the notable exception of Mycobacterium tuberculosis (Mtb) 29 the agent of tuberculosis (TB), all other Bacterial species listed as current AMR threats By the 30 Centers for Disease Control http://www.cdc.gov/drugresistance/Biggest_threats.htmltrend 31 frequently exchange genetic material and frequently acquire novel mutations through gain of 32 new genes By horizontal gene transfer (HGT) rather than de novo mutations (Figure 1). -
Omics Based Approaches to Study Campylobacter Jejuni Pathogenesis
Omics based approaches to study Campylobacter jejuni pathogenesis Ozan Gundogdu 2020 This research dissertation is submitted for the MSc in Bioinformatics at Queen Mary, University of London 1 Table of Contents Abstract .................................................................................................................................. 3 Acknowledgements ................................................................................................................ 5 1. Introduction ........................................................................................................................ 6 1.1 Campylobacter ............................................................................................................. 6 1.1 Next-generation sequencing ......................................................................................... 6 1.3 16S metagenomics ....................................................................................................... 7 1.4 Operational Taxonomic Units (OTUs) ......................................................................... 8 1.5 Amplicon Sequence Variants (ASVs) .......................................................................... 9 1.6 Data analysis .............................................................................................................. 10 1.6 Bacterial transcriptomics ............................................................................................ 11 1.7 Bacterial transcriptomics data analysis ..................................................................... -
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Study of the Oral Virome and Microbiome Associated to the Proliferative Verrucous Leukoplakia
Study of the oral virome and microbiome associated to the proliferative verrucous leukoplakia Doctorando: Rodrigo García López Programa: 1393/2007 Biotecnología, FACULTAT DE CIÈNCIES BIOLÒGIQUES Directores: Andrés Moya Simarro Vicente Pérez Brocal Valencia, 2017 D. Andrés Moya, Catedrático del Departamento de Genética de la Universitat de València y D. Vicente Pérez Brocal, Investigador del Centro de Investigación Biomédica en Red (Epidemiología y Salud Pública) (CIBERESP), certifican que la memoria titulada “Study of the oral virome and microbiome associated to the proliferative verrucous leukoplakia” ha sido realizada bajo su dirección en la Unidad Mixta de Investigación en Genómica y Salud FISABIO-Salud Pública -Instituto Cavanilles de Biodiversidad y Biologia Evolutiva, Universitat de València. Y para que así conste, firman el presente certificado. Fdo. Dr. Andrés Moya Fdo. Dr. Vicente Pérez Brocal Valencia, a _____________________________________________ Agradecimientos A mi esposa, Letty por el enorme apoyo y cariño en estos momentos tan complicados. A Andrés por su interminable paciencia y la motivación para seguir adelante. A Vicente y Ma. José por la valiosa guía tanto en lo académico como en la vida. A Jorge y Bea por la amistad que tanta falta hace para poder disfrutar del trabajo. A Maria por marcar la pauta y recordarme siempre hay algo positivo en todo. A los compañeros del laboratorio por la convivencia y a los técnicos por su imprescindible ayuda. A los que ya no están, los que nos dejaron pero a quienes recordamos con mucho cariño. A mi papá, por los valiosos consejos que quisiera seguir más frecuentemente. A mi mamá por ser quien me aterriza en la realidad cuando divago. -
The Human Microbiome, Diet, and Health: Workshop Summary
This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=13522 The Human Microbiome, Diet, and Health: Workshop Summary ISBN Leslie Pray, Laura Pillsbury, and Emily Tomayko, Rapporteurs; Food 978-0-309-26585-0 Forum; Food and Nutrition Board; Institute of Medicine 181 pages 6 x 9 PAPERBACK (2013) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. The Human Microbiome, Diet, and Health: Workshop Summary Workshop Summary The Human Microbiome, Diet, and Health Leslie Pray, Laura Pillsbury, and Emily Tomayko, Rapporteurs Food Forum Food and Nutrition Board Copyright © National Academy of Sciences. All rights reserved. The Human Microbiome, Diet, and Health: Workshop Summary THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Govern- ing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineer- ing, and the Institute of Medicine. This study was supported by Contract Nos. -
Skin Microbiome Analysis for Forensic Human Identification: What Do We Know So Far?
microorganisms Review Skin Microbiome Analysis for Forensic Human Identification: What Do We Know So Far? Pamela Tozzo 1,*, Gabriella D’Angiolella 2 , Paola Brun 3, Ignazio Castagliuolo 3, Sarah Gino 4 and Luciana Caenazzo 1 1 Department of Molecular Medicine, Laboratory of Forensic Genetics, University of Padova, 35121 Padova, Italy; [email protected] 2 Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy; [email protected] 3 Department of Molecular Medicine, Section of Microbiology, University of Padova, 35121 Padova, Italy; [email protected] (P.B.); [email protected] (I.C.) 4 Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0498272234 Received: 11 May 2020; Accepted: 8 June 2020; Published: 9 June 2020 Abstract: Microbiome research is a highly transdisciplinary field with a wide range of applications and methods for studying it, involving different computational approaches and models. The fact that different people host radically different microbiota highlights forensic perspectives in understanding what leads to this variation and what regulates it, in order to effectively use microbes as forensic evidence. This narrative review provides an overview of some of the main scientific works so far produced, focusing on the potentiality of using skin microbiome profiling for human identification in forensics. This review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The examined literature clearly ascertains that skin microbial communities, although personalized, vary systematically across body sites and time, with intrapersonal differences over time smaller than interpersonal ones, showing such a high degree of spatial and temporal variability that the degree and nature of this variability can constitute in itself an important parameter useful in distinguishing individuals from one another. -
Potential Role of Microbiome in Oncogenesis, Outcome Prediction
Oral Oncology 99 (2019) 104453 Contents lists available at ScienceDirect Oral Oncology journal homepage: www.elsevier.com/locate/oraloncology Review Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer T ⁎ Ester Orlandia,b, , Nicola Alessandro Iacovellib, Vincenzo Tombolinic, Tiziana Rancatid, Antonella Polimenie, Loris De Ceccof, Riccardo Valdagnia,d,g, Francesca De Felicec a Department of Radiotherapy 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy b Department of Radiotherapy 2, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy c Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy d Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy e Department of Oral and Maxillo Facial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Italy f Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy g Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy ARTICLE INFO ABSTRACT Keywords: In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine Head and neck cancer and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the Biomarkers biggest potential to be investigated. Microbiome Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the Microbiota link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. Oncogenesis However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral mi- Radiotherapy Immunotherapy crobiome and HNC could have important consequences for prevention and early detection of this type of tumors. -
Integrating Taxonomic, Functional, and Strain-Level Profiling of Diverse
TOOLS AND RESOURCES Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 Francesco Beghini1†, Lauren J McIver2†, Aitor Blanco-Mı´guez1, Leonard Dubois1, Francesco Asnicar1, Sagun Maharjan2,3, Ana Mailyan2,3, Paolo Manghi1, Matthias Scholz4, Andrew Maltez Thomas1, Mireia Valles-Colomer1, George Weingart2,3, Yancong Zhang2,3, Moreno Zolfo1, Curtis Huttenhower2,3*, Eric A Franzosa2,3*, Nicola Segata1,5* 1Department CIBIO, University of Trento, Trento, Italy; 2Harvard T.H. Chan School of Public Health, Boston, United States; 3The Broad Institute of MIT and Harvard, Cambridge, United States; 4Department of Food Quality and Nutrition, Research and Innovation Center, Edmund Mach Foundation, San Michele all’Adige, Italy; 5IEO, European Institute of Oncology IRCCS, Milan, Italy Abstract Culture-independent analyses of microbial communities have progressed dramatically in the last decade, particularly due to advances in methods for biological profiling via shotgun metagenomics. Opportunities for improvement continue to accelerate, with greater access to multi-omics, microbial reference genomes, and strain-level diversity. To leverage these, we present bioBakery 3, a set of integrated, improved methods for taxonomic, strain-level, functional, and *For correspondence: phylogenetic profiling of metagenomes newly developed to build on the largest set of reference [email protected] (CH); sequences now available. Compared to current alternatives, MetaPhlAn 3 increases the accuracy of [email protected] (EAF); taxonomic profiling, and HUMAnN 3 improves that of functional potential and activity. These [email protected] (NS) methods detected novel disease-microbiome links in applications to CRC (1262 metagenomes) and †These authors contributed IBD (1635 metagenomes and 817 metatranscriptomes). -
3. Jedna Z Krvných Skupín Systému AB0; 4. Skr. Bukálny. B – Symbo
B – 1. symbol pre bel; 2. chem. značka prvku →bór; 3. jedna z krvných skupín systému AB0; 4. skr. bukálny. B – symbol pre hustotu magnetického toku. B. – skr. pre →Bacillus. B-ALP – skr. angl. bone alcalic phosphatase kostná alkalická fosfatáza. B-bunky – 1. syn. -bunky Langerhansových ostrovčekov; →pankreas; 2. syn. B-lymfocyty; →lymfocyty. B-komplex – multivitamínový prípravok vitamínov B. B-lymfocyty – [B podľa Fabriciovej burzy, imunol. orgánu vtákov] B bunky, druh lymfocytov, kt. sa zúčastňuje na humorálnej imunite (tvorbe protilátok) a niekt. ďalších imunitných funkciách. Povrchové molekuly sú CD 19,20. Receptorom pre antigén je membránový imunoglobulín. B-reťazec – jeden z polypeptidových reťazcov →inzulínu. B-vírus – 1. vírus →hepatitídy B.; 2. vírus zo skupiny Cercopithecine herpes virus 1. B-vlákna →nerv. b – skr. 1. pre barn; 2. skr. angl. born narodený; 3. skr. báza (genet. označenie dĺţky sekvencie nukleotidov, napr. 50 b = sekvencia 50 nukleotidov). b-vlna – pozit. kmit s vyskou amplitúdou v →elektroretinograme nasledujúci po vlne a, prejav komplexnej aktivity vrstvy bipolárnych buniek. – - – predpona označujúca 1. staršie označenie druhého atómu uhlíka v reťazci, na kt. sa pripája hlavná funkčná skupina, napr. kys. -hydroxymaslová správ. kys. 3-hydroxymaslová; 2. špecifická rotácia opticky aktívnej látky, napr. -D-glukóza; 3. orientácia exocyklického atómu al. skupiny, napr. cholest-5-en-3--ol; 4. plazmatický proteín, kt. migruje v elektroforéze v pruhu - lipoproteín; 5. člen série príbuzných chem. látok, najmä série stereoizomérov, izomérov, polymérov al. alotroických foriem, napr. -karotén; 6. -lúč. B2 – staršie označenie pre CD21. B4 – staršie označenie pre CD 19. B19 virus – ľudský parvovírus z čeľade Parvoviridae, značne rozšírený, vyvolávajúci obvykle inaparentné infekcie. -
974-Form.Pdf
California Association for Medical Laboratory Technology Distance Learning Program ANAEROBIC BACTERIOLOGY FOR THE CLINICAL LABORATORY by James I. Mangels, MA, CLS, MT(ASCP) Consultant Microbiology Consulting Services Santa Rosa, CA Course Number: DL-974 3.0 CE/Contact Hour Level of Difficulty: Intermediate © California Association for Medical Laboratory Technology. Permission to reprint any part of these materials, other than for credit from CAMLT, must be obtained in writing from the CAMLT Executive Office. CAMLT is approved by the California Department of Health Services as a CA CLS Accrediting Agency (#0021) and this course is is approved by ASCLS for the P.A.C.E. ® Program (#519) 1895 Mowry Ave, Suite 112 Fremont, CA 94538-1766 Phone: 510-792-4441 FAX: 510-792-3045 Notification of Distance Learning Deadline All continuing education units required to renew your license must be earned no later than the expiration date printed on your license. If some of your units are made up of Distance Learning courses, please allow yourself enough time to retake the test in the event you do not pass on the first attempt. CAMLT urges you to earn your CE units early!. CAMLT Distance Learning Course # DL-974 1 © California Association for Medical Laboratory Technology Outline A. Introduction B. What are anaerobic bacteria? Concepts of anaerobic bacteriology C. Why do we need to identify anaerobes? D. Normal indigenous anaerobic flora; the incidence of anaerobes at various body sites E. Anaerobic infections; most common anaerobic infections F. Specimen collection and transport; acceptance and rejection criteria G. Processing of clinical specimens 1. Microscopic examination 2.